1-4 of 4
Jason Shafrin
Close
Sort by
Journal Articles

Cost to Treat Newly Diagnosed Patients with Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Analysis

Anem Waheed, Denise Clayton, Jason Shafrin, Frank Li, Yulin Shi, Lincy Geevarghese, Glorian P. Yen
Journal: Blood
Blood (2022) 140 (Supplement 1): 5033–5034.
https://doi.org/10.1182/blood-2022-158358
Published: 2022
Journal Articles

How Does Sickle Cell Disease Severity Affect Patient Collection of Disability Insurance and Income: An Analysis of US Survey Data

Jason Shafrin, Howard Z. Thom, Daisy Gaunt, Lauren M. Zhao, George J Joseph, Menaka Bhor, PhD, Avery A. Rizio, Lanetta Bronté-Hall, MPH, MSPH, MD, Nirmish Shah
Journal: Blood
Blood (2019) 134 (Supplement_1): 5781.
https://doi.org/10.1182/blood-2019-122774
Published: 2019
Journal Articles

Quantifying the Economic Burden of Myelodysplastic Syndromes Among Elderly US Patients

Jason Shafrin, PhD, Sarah Green, BA, Richard Murphy, BA, Katie Everson, MS, Syvart Dennen, M.Phil, Kwanza Price, MPH, Katharine Batt, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 2151.
https://doi.org/10.1182/blood-2019-124216
Published: 2019
Journal Articles

Relationship between Vaso-Occlusive Crisis and Quality of Life: An Analysis of Patients with Sickle Cell Disease in the United States

Howard Z. Thom, Jason Shafrin, Edna Keeney, Lauren M. Zhao, George J Joseph, Menaka Bhor, PhD, Avery A. Rizio, Lanetta Bronté-Hall, MPH, MSPH, MD, Nirmish Shah
Journal: Blood
Blood (2019) 134 (Supplement_1): 4700.
https://doi.org/10.1182/blood-2019-124132
Published: 2019